Close

Analyst Ratings for Cabaletta Bio Inc. (CABA)

CABA Rating Summary

CABA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CABA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $13.50 (+13.8%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/27/2023 Morgan Stanley Michael Ulz Upgrade Overweight
(Equalweight)
16.00
(3.00)
11.12
(11.86)
6.65% Details
12/8/2021 Wells Fargo
» Updated 1/3/2023
Chris M. Carey New Coverage Overweight
(N/A)
14.00
(4.00)
10.68
(11.86)
11.05% Details
Like CABA Ratings? Also take a look at AFRM, ERIC, AI, CRNC

CABA Ratings News